v3.21.1
Condensed Consolidated Statements of Changes in Equity (Deficiency) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional paid-in capital
Treasury Stock
Subscription receivable
Accumulated deficit
Accumulated other comprehensive loss
Noncontrolling interest
Total
Balance at Jun. 30, 2019 $ 26,523,830 $ 2,066,906 $ (417,538) $ (6,968,700) $ (671,106) $ (5,173,622) $ 15,359,770
Balance (in Shares) at Jun. 30, 2019 3,210,907 [1]   (35,099) [1]          
Stock based compensation to employee $ 63,000 63,000
Stock based compensation to employee (in Shares) 18,000 [1]   [1]          
Stock based compensation to consultants $ 200,300 200,300
Stock based compensation to consultants (in Shares) 48,000 [1]   [1]          
Amortization of shares issued to consultants 180,209 180,209
Foreign currency translation (646,211) 142,544 (503,667)
Net loss (1,627,353) (121,271) (1,748,624)
Balance at Sep. 30, 2019   $ 26,787,130 2,247,115 $ (417,538) (8,596,053) (1,317,317) (5,152,349) 13,550,988
Balance (in Shares) at Sep. 30, 2019 [1]   3,276,907   (35,099)          
Balance at Jun. 30, 2019 $ 26,523,830 2,066,906 $ (417,538) (6,968,700) (671,106) (5,173,622) 15,359,770
Balance (in Shares) at Jun. 30, 2019 3,210,907 [1]   (35,099) [1]          
Net loss                 (6,314,972)
Balance at Mar. 31, 2020   $ 28,090,992 2,334,962 (114,054) (12,821,480) (1,142,737) (5,524,315) 10,823,368
Balance (in Shares) at Mar. 31, 2020 [1]   3,627,808            
Balance at Sep. 30, 2019   $ 26,787,130 2,247,115 $ (417,538) (8,596,053) (1,317,317) (5,152,349) 13,550,988
Balance (in Shares) at Sep. 30, 2019 [1]   3,276,907   (35,099)          
Stock based compensation to employee $ 156,400 156,400
Stock based compensation to employee (in Shares) [1]   46,000              
Stock based compensation to consultants   $ 282,500             282,500
Stock based compensation to consultants (in Shares) [1]   70,000              
Amortization of shares issued to consultants 52,708 52,708
Issuance of common stock to private investor $ 500,500 500,500
Issuance of common stock to private investor (in Shares) [1]   100,100              
Cancellation of treasury stock $ (417,538) $ 417,538
Cancellation of treasury stock (in Shares) [1]   (35,099)   35,099          
Foreign currency translation 350,015 (93,809) 256,206
Net loss (407,333) 43,978 (363,355)
Balance at Dec. 31, 2019 $ 27,308,992 2,299,823 (9,003,386) (967,302) (5,202,180) 14,435,947
Balance (in Shares) at Dec. 31, 2019 [1]   3,457,908            
Stock based compensation to consultants $ 282,500 282,500
Stock based compensation to consultants (in Shares) [1]   70,000              
Amortization of shares issued to consultants 35,139 35,139
Issuance of common stock to private investor $ 499,500 (114,054) 385,446
Issuance of common stock to private investor (in Shares) [1]   99,900              
Foreign currency translation (175,435) 62,764 (112,671)
Net loss (3,818,094) (384,899) (4,202,993)
Balance at Mar. 31, 2020   $ 28,090,992 2,334,962 (114,054) (12,821,480) (1,142,737) (5,524,315) 10,823,368
Balance (in Shares) at Mar. 31, 2020 [1]   3,627,808            
Balance at Jun. 30, 2020 $ 28,414,992 2,334,962 (59,869) (23,421,594) (1,084,030) (6,542,361) (357,900)
Balance (in Shares) at Jun. 30, 2020 3,718,788 [1]              
Issuance of common stock to private investor $ 1,051,200 59,869 1,111,069
Issuance of common stock to private investor (in Shares) 720,000 [1]              
Foreign currency translation 191,251 (198,824) (7,573)
Net loss (733,791) (14,665) (748,456)
Balance at Sep. 30, 2020 $ 29,466,192 2,334,962 (24,155,385) (892,779) (6,755,850) (2,860)
Balance (in Shares) at Sep. 30, 2020 [1]   4,438,788            
Balance at Jun. 30, 2020 $ 28,414,992 2,334,962 (59,869) (23,421,594) (1,084,030) (6,542,361) (357,900)
Balance (in Shares) at Jun. 30, 2020 3,718,788 [1]              
Net loss                 (5,360,965)
Balance at Mar. 31, 2021 $ 82,555,700 2,334,962 (28,739,565) (733,247) (6,969,926) 48,447,924
Balance (in Shares) at Mar. 31, 2021 14,961,999 [1]   [1]          
Balance at Sep. 30, 2020 $ 29,466,192 2,334,962 (24,155,385) (892,779) (6,755,850) (2,860)
Balance (in Shares) at Sep. 30, 2020 [1]   4,438,788            
Issuance of preferred stock to private investor $ 1,427,600 1,427,600
Issuance of preferred stock to private investor (in Shares) 860,000                
Issuance of common stock to private investor $ 4,322,330 4,322,330
Issuance of common stock to private investor (in Shares) [1]   1,560,000              
Foreign currency translation 235,865 (204,827) 31,038
Net loss (1,102,919) 9,359 (1,093,560)
Balance at Dec. 31, 2020 $ 1,427,600 $ 33,788,522 2,334,962 (25,258,304) (656,914) (6,951,318) 4,684,548
Balance (in Shares) at Dec. 31, 2020 860,000 5,998,788 [1]   [1]          
Issuance of common stock to private investor $ 42,535,678 42,535,678
Issuance of common stock to private investor (in Shares) [1]   6,740,456              
Conversion of preferred stock into common stock $ (1,427,600) $ 1,427,600
Conversion of preferred stock into common stock (in Shares) (860,000) 860,000 [1]              
Exercise of stock warrants $ 4,803,900 4,803,900
Exercise of stock warrants (in Shares) [1]   1,362,755              
Foreign currency translation (76,333) 19,080 (57,253)
Net loss (3,481,261) (37,688) (3,518,949)
Balance at Mar. 31, 2021 $ 82,555,700 $ 2,334,962 $ (28,739,565) $ (733,247) $ (6,969,926) $ 48,447,924
Balance (in Shares) at Mar. 31, 2021 14,961,999 [1]   [1]          
[1] Shares and per share data are presented on a retroactive basis to reflect the 1-for-5 reverse stock split on July 7, 2020.